Expression of HER-2/neu in ovarian cancer and its clinical significance

ZHU Hai-yan,BAO Xiang-xiang,ZHENG Fei-yun,LIN Feng,YANG Xiao-jun,LIN Feng
2008-01-01
Abstract:Objective To investigate the expression of human epidermal growth factor receptor 2(HER-2 /neu) in epithelial ovarian cancer patients and its clinical significance.Methods The expressions of HER-2 /neu were detected in 52 patients with ovarian cancer,10 patients with borderline ovarian tumor,and 10 patients with benign epithelial ovarian tumor by SP immunohistochemistry.Results The positive rate of HER-2 /neu was markedly higher in ovarian cancer than in borderline ovarian tumor or benign epithelial ovarian tumor(P=0.045).HER-2 /neu expression was not associated with the histological types,pathologic grades,and clinical stages(P > 0.05).The average survival time was shorter in patients with HER-2 /neu positive tumor than in those with HER-2 /neu negative tumor(16.9 months vs 40.7 months),showing a significant difference by the log-rank test(P=0.005).Conclusion The overexpression of HER-2 /neu may play a role in the carcinogenesis and development of ovarian cancer,shortens the postoperative survival time,and is a poor prognostic factor for epithelial ovarian cancer.
What problem does this paper attempt to address?